CONTI, GIUSEPPE NICOLO'
 Distribuzione geografica
Continente #
AS - Asia 54
NA - Nord America 44
EU - Europa 41
SA - Sud America 12
AF - Africa 7
Totale 158
Nazione #
US - Stati Uniti d'America 43
IT - Italia 37
SG - Singapore 24
CN - Cina 19
BR - Brasile 11
CI - Costa d'Avorio 6
KR - Corea 5
IN - India 3
NL - Olanda 2
CR - Costa Rica 1
DE - Germania 1
EC - Ecuador 1
FI - Finlandia 1
HK - Hong Kong 1
IQ - Iraq 1
TN - Tunisia 1
VN - Vietnam 1
Totale 158
Città #
Dallas 15
Singapore 13
Santa Clara 12
Hefei 11
Catania 10
Abidjan 6
Seoul 5
Carrara 4
Los Angeles 4
New York 4
Rome 4
Beijing 3
Vasto 3
Aci Catena 2
Ashburn 1
Baghdad 1
Bengaluru 1
Boston 1
Brooklyn 1
Charlotte 1
Chicago 1
Civitanova Marche 1
Fouchana 1
Frankfurt am Main 1
Guangzhou 1
Hong Kong 1
Kochi 1
Lages 1
Lappeenranta 1
Maceió 1
Matinhos 1
Milan 1
Mobile 1
Mogi das Cruzes 1
New Delhi 1
Nova Odessa 1
Panelas 1
Paso Canoas 1
Porto Alegre 1
Quảng Ninh 1
Rio de Janeiro 1
San Gregorio di Catania 1
Santa Elena 1
Santo André 1
Syracuse 1
São Paulo 1
Tremestieri Etneo 1
Vespasiano 1
Totale 130
Nome #
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 62
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma 52
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 28
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 21
Totale 163
Categoria #
all - tutte 512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202587 0 0 0 7 5 19 6 9 5 8 13 15
2025/202676 10 24 36 6 0 0 0 0 0 0 0 0
Totale 163